The data shown below were collected from the profiles of 1,456 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes
|
|---|---|
| Published in |
New England Journal of Medicine, May 2024
|
| DOI | 10.1056/nejmoa2403347 |
| Pubmed ID | |
| Authors |
Vlado Perkovic, Katherine R Tuttle, Peter Rossing, Kenneth W Mahaffey, Johannes F E Mann, George Bakris, Florian M M Baeres, Thomas Idorn, Heidrun Bosch-Traberg, Nanna Leonora Lausvig, Richard Pratley |
X Demographics
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Brazil | 75 | 5% |
| United States | 73 | 5% |
| United Kingdom | 22 | 2% |
| Saudi Arabia | 12 | <1% |
| Spain | 10 | <1% |
| Mexico | 8 | <1% |
| India | 7 | <1% |
| Japan | 5 | <1% |
| Canada | 5 | <1% |
| Other | 51 | 4% |
| Unknown | 1188 | 82% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 1060 | 73% |
| Scientists | 194 | 13% |
| Practitioners (doctors, other healthcare professionals) | 185 | 13% |
| Science communicators (journalists, bloggers, editors) | 17 | 1% |
Mendeley readers
The data shown below were compiled from readership statistics for 205 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 205 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Unspecified | 50 | 24% |
| Researcher | 19 | 9% |
| Other | 18 | 9% |
| Professor > Associate Professor | 14 | 7% |
| Student > Master | 12 | 6% |
| Other | 41 | 20% |
| Unknown | 51 | 25% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 71 | 35% |
| Unspecified | 48 | 23% |
| Pharmacology, Toxicology and Pharmaceutical Science | 8 | 4% |
| Biochemistry, Genetics and Molecular Biology | 6 | 3% |
| Computer Science | 3 | 1% |
| Other | 17 | 8% |
| Unknown | 52 | 25% |
Attention Score in Context
This research output has an Altmetric Attention Score of 2629. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 September 2024.
All research outputs
#2,956
of 26,588,548 outputs
Outputs from New England Journal of Medicine
#191
of 33,153 outputs
Outputs of similar age
#36
of 327,843 outputs
Outputs of similar age from New England Journal of Medicine
#2
of 240 outputs
Altmetric has tracked 26,588,548 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 33,153 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 124.3. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 327,843 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 240 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.